NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/27/2025
Back to search
Official data from USPTO
BIOPHARM ENGINEERED SYSTEMS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIOPHARM ENGINEERED SYSTEMS
ST13
US500000087856709Class
7, 9
Filing
87856709
Registration
5778812
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
08/28/2025
Trademark type
Word
Nice classes
7, 9
Filing date
03/30/2018
Registration date
06/18/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2025
Last transaction
08/28/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/16/2007
First use in commerce
07/16/2007
Drawing code
4
Owner type
03
Owner location
MILPITAS, CA
Examiner
MUNN LEWIS, LAKEISHA
Current location
Historical data usage
Holders and representatives
Holders
EXENTEC U.S., INC.
BioPharm Engineered Systems, LLC
Representatives
Peter Kunin DOWNS RACHLIN MARTIN PLLC
Technical classification
Nice Classes
Class 7Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 7
Custom process machinery for manufacturing and developing biological pharmaceutical productsfiltration equipmentfilter housings for filtration equipmentcentrifugesother custom process equipmentultra filtrationmicro filtrationnano filtrationin-line dilutiondepth filtrationdead ended filtrationsingle use filtration systems
Class 9
Chromatography equipment for separation and purificationhigh pressure liquid chromatography systems (HPLC)low pressure liquid chromatography systems (LPLC)
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/27/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/27/2025
E815
TEAS SECTION 8 & 15 RECEIVED
04/22/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/14/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/02/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/18/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/02/2019
PUBO
PUBLISHED FOR OPPOSITION
04/02/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/13/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2019
ALIE
ASSIGNED TO LIE
01/28/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/22/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/23/2018
GNRT
NON-FINAL ACTION E-MAILED
07/23/2018
CNRT
NON-FINAL ACTION WRITTEN
07/23/2018
DOCK
ASSIGNED TO EXAMINER
07/17/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2018
NWAP
NEW APPLICATION ENTERED
04/03/2018
Continuous trademark protection
Get notified about every new filing that threatens BIOPHARM ENGINEERED SYSTEMS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.